R

Rejuveron Life Sciences AG

21 employees

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

Investor insights

Sectors invested in

Biotechnology2

Therapeutics2

Medical2

Aging1

Health Care1

c.elegans1

Healthspan1

Sarcopenia1

Healthcare1

Mouse1

Funding rounds participated in

$18M sweet spot round size

Most of their 3 investments are in rounds between $8M and $18M

Investor type

Incubator

Private Equity Firm

Venture Capital

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Medical

Date founded

2019

Investments made

E

Endogena Therapeutics, Inc. raised $21M on December 13, 2021

Investors: DEFTA Partners and Rejuveron Life Sciences AG

R

Rejuvenate Biomed raised $18M on October 12, 2021

Investors: Vesalius Biocapital and Rejuveron Life Sciences AG

E

Endogena Therapeutics, Inc. raised $8M on January 28, 2021